The associations between daily spring pollen counts, over-the-counter allergy medication sales, and asthma syndrome emergency department visits in New York City, 2002-2012 by unknown
RESEARCH Open Access
The associations between daily spring pollen
counts, over-the-counter allergy medication
sales, and asthma syndrome emergency
department visits in New York City, 2002-2012
Kazuhiko Ito1*, Kate R. Weinberger2, Guy S. Robinson3,4, Perry E. Sheffield5, Ramona Lall6, Robert Mathes6,
Zev Ross7, Patrick L. Kinney2 and Thomas D. Matte1
Abstract
Background: Many types of tree pollen trigger seasonal allergic illness, but their population-level impacts on
allergy and asthma morbidity are not well established, likely due to the paucity of long records of daily pollen data
that allow analysis of multi-day effects. Our objective in this study was therefore to determine the impacts of
individual spring tree pollen types on over-the-counter allergy medication sales and asthma emergency department
(ED) visits.
Methods: Nine clinically-relevant spring tree pollen genera (elm, poplar, maple, birch, beech, ash, sycamore/London
planetree, oak, and hickory) measured in Armonk, NY, were analyzed for their associations with over-the-counter
allergy medication sales and daily asthma syndrome ED visits from patients’ chief complaints or diagnosis codes
in New York City during March 1st through June 10th, 2002-2012. Multi-day impacts of pollen on the outcomes
(0-3 days and 0-7 days for the medication sales and ED visits, respectively) were estimated using a distributed
lag Poisson time-series model adjusting for temporal trends, day-of-week, weather, and air pollution. For asthma
syndrome ED visits, age groups were also analyzed. Year-to-year variation in the average peak dates and the
10th-to-90th percentile duration between pollen and the outcomes were also examined with Spearman’s rank
correlation.
Results: Mid-spring pollen types (maple, birch, beech, ash, oak, and sycamore/London planetree) showed the
strongest significant associations with both outcomes, with cumulative rate ratios up to 2.0 per 0-to-98th
percentile pollen increase (e.g., 1.9 [95 % CI: 1.7, 2.1] and 1.7 [95 % CI: 1.5, 1.9] for the medication sales and ED
visits, respectively, for ash). Lagged associations were longer for asthma syndrome ED visits than for the
medication sales. Associations were strongest in children (ages 5-17; e.g., a cumulative rate ratio of 2.6 [95 % CI:
2.1, 3.1] per 0-to-98th percentile increase in ash). The average peak dates and durations of some of these
mid-spring pollen types were also associated with those of the outcomes.
Conclusions: Tree pollen peaking in mid-spring exhibit substantive impacts on allergy, and asthma
exacerbations, particularly in children. Given the narrow time window of these pollen peak occurrences, public
health and clinical approaches to anticipate and reduce allergy/asthma exacerbation should be developed.
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Background
Tree pollens have been associated with higher rates of
allergic sensitization [1–3], over-the-counter allergy
medication sales [4], prescribed medication use for aller-
gic rhinitis, rhinosinusitus, and conjunctivitis [5], asthma
symptoms [6], asthma emergency department (ED) visits
[7–11], and asthma hospitalizations [12, 13]. Allergic
rhinitis, a risk factor for increased asthma severity, with
a reported prevalence of up to 100 % in those with aller-
gic asthma [14], affects an estimated 10 ~ 30 % of the
world population [15]. The estimated direct costs for al-
lergic rhinitis alone, including both health services and
prescription medication sales, were $11.2 billion in the
U.S. in 2005 [16]. In a large survey of pediatric patients
and parents of patients with allergy, 54 % reported the
use of an over-the-counter (OTC) allergy medication
during the past 4 weeks [17]. Asthma affects 1 in 12
people in the U.S. [18]. Emergency department visits for
asthma account for a major fraction (~$1 billion in the
U.S. in 2006) of the direct cost of asthma [19]. Thus,
estimating the impacts of spring tree pollen on these
outcomes is relevant to public health policy.
The observational epidemiological studies mentioned
above found associations with either individual tree
pollen types or total tree pollen counts. Of the seven
U.S. and Canadian studies that examined the associa-
tions between pollen and asthma emergency department
visits or hospitalizations [7–13], only two studies, a
study in Atlanta, GA [9], and a ten-city study in Canada
[13] evaluated the impacts of individual tree pollen
types. However, the dominant taxa and mix of tree pol-
lens vary from city-to-city. The impact of climate change
on the relevant characteristics (i.e., season length, start-
ing date, etc.) of tree pollens are also likely different
from pollen to pollen and across different climatic re-
gions [20]. Thus, to estimate the impacts of tree pollens
on asthma and allergy health outcomes and to develop a
public health policy to mitigate their adverse effects in
the future, epidemiological analysis will need to consider
individual pollen types, each of which may be impacted
differently by climate change.
Previously, we reported that the peak dates (an 1/0 in-
dicator variable, based on measurements around the es-
timated peak periods) of three tree pollen genera, maple,
oak, and birch (but not elm) were associated with daily
OTC allergy medication sales during the years 2003-
2008 [4]. Since then, we have developed an extensive
database of daily concentrations of spring tree pollens
for years 2002-2012 by reviewing archived pollen slides.
We believe that this daily pollen database has an
uniquely high level of completeness compared to other
available data (e.g., National Allergy Bureau recommends
that its monitoring stations report 3 out of every 7 days),
as we have all days of the week except for days where
the sampler malfunctioned. Thus, the objective of this
study is to investigate the multi-day association between
daily measurements of individual spring tree pollen gen-
era and the OTC allergy medication sales as well as
asthma ED visits syndrome data (“asthma syndrome ED
visits”), with a focus on the relative importance of indi-
vidual pollen types, the timing and magnitude of their
impacts, and the consistency between these allergy and
asthma indicators, which we monitor on a daily basis as




Airborne pollen was collected with a Burkard volumetric
spore trap (Burkard manufacturing Co., Rickmansworth,
UK) located on the rooftop of Fordham University’s
Louis Calder Biological Station in Armonk, NY, about
30 miles north of Manhattan. This station provides the
closest long-term pollen record for the New York City
(NYC) region. Most slides have exposure periods that
run from around 9 am to 9 am (a sample that starts at
9 am today represents the measurement for today), ex-
cept all samples in 2002 and March 1-14, 2004 (2 pm to
2 pm; a sample that starts at 2 pm today represents the
measurement for tomorrow) and all samples in 2011
and 2012 (midnight to midnight sample). Trained coun-
ters conducted microscopic analysis of pollen. Resulting
daily pollen counts were converted into concentrations
in particles per cubic meter of air for the eleven years
from 2002 to 2012.
We identified nine tree pollen genera for analysis on
the basis of clinical significance in the U.S. and observed
sensitization patterns in the Northeastern U.S. and NYC
[3, 21, 22] (species name in italic): Acer (maple), Betula
(birch), Quercus (oak), Ulmus (elm), Fraxinus (ash), Pla-
tanus (sycamore/London planetree), Fagus (beech),
Carya (hickory), and Populus (poplar). We use the com-
mon name (e.g., maple) from here on. We chose a data
analysis period of March 1st through June 10th, 2002-
2012 to cover peak periods of these pollen types. Missing
values (7 %) were imputed using the average of sur-
rounding values. The majority of the missing data (46 %
of the 7 %) occurred consecutively in the beginning of
the sampling period (before March 15th) when most of
the pollen genera showed zero or very low measured
values afterwards.
Health outcome data
OTC allergy medication sales data: Data on OTC phar-
macy sales are reported electronically to the New York
City Department of Health (NYCDOH) on a daily basis
from over 200 stores from a major pharmacy chain, dis-
proportionately in Manhattan (the most densely populated
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borough of NYC). The number of pharmacies reporting
sales data fluctuated day to day, but during the study
period, about 20 to 25 % of stores in Manhattan reported
data to NYCDOH. The following brand-name and generic
products were classified as allergy medications: Alavert,
Benadryl, cetirizine, Claritin, loratidine, Sudafed, Tavist,
and Zyrtec, as well as other medications described with
the word “allergy”. The unit of this allergy indicator is the
number of units sold per day. On the average, the percent-
ages of units sold in five boroughs were: Manhattan
(75 %); the Bronx (3 %); Brooklyn (10 %); Queens (10 %);
and Staten Island (2 %). Despite the disproportionate sales
across boroughs, the daily sales counts during the spring
study period were highly correlated across boroughs,
ranging from r = 0.83 (Manhattan vs. Staten Island) to
r = 0.98 (Brooklyn vs. Queens), indicating high spatial
uniformity of temporal variations in this ecologic allergy
indicator within the city. The coverage of stores changed
in late 2011, and therefore, for OTC allergy medication
sales data, analysis was limited to the years 2002-2011.
Asthma syndrome ED visits data: During the study
period, NYCDOH electronically received data from 52
hospitals (~95 % of annual ED visits in NYC). Data files
contain date of visit, age, sex, residential zip code, and
free-text chief complaint (the patient’s own description
of his/her illness). The ED visits data are used to investi-
gate aberrations in various illnesses, including asthma,
diarrhea, and influenza-like illness [23]. The ED visits
data are categorized into exclusive “syndromes” based
on the patient’s chief complaint, using an algorithm that
scans the chief complaint field for character strings
assigned to a syndrome. For asthma ED syndrome, the
script searched for the word “asthma”, “wheezing”,
“COPD”, their common misspelled analogues and Inter-
national Classification of Diseases 9th edition codes asso-
ciated with asthma (because some hospitals report
diagnosis codes). We analyzed asthma syndrome ED
visits for all ages and by age group: (1) 0-4; (2) 5-17; (3)
18-39; (4) 40-64; and (5) 65+. Based on the physician-
diagnosed asthma ED visits data during the years 2005-
2009 available from the New York State’s Statewide
Planning and Research Cooperative System, we found
that the temporal correlations between the daily asthma
syndrome ED visits (the data we used in this analysis)
and the physician-diagnosed asthma ED visits were high
(Pearson correlation = 0.95). The correlations for specific
age-groups were also high except the oldest age group:
0.91, 0.96, 0.91, 0.83, and 0.53 respectively, for the age
groups noted above. Thus, the asthma syndrome ED
visits data are a very good indicator of daily variation in
physician-diagnosed asthma ED visits, except for the
elderly group.
The main difference between the OTC allergy medica-
tion sales data and asthma ED visits syndrome data in
terms of their seasonal pattern is that, while the spring
peaks are the most dominant feature of the OTC allergy
medication sales data, asthma ED visits syndrome data
also exhibit other seasonal variations such as sharp rise
in September, with the counts remaining high through
the winter period. However, the sharp spring peaks in
counts are the common feature in these two outcomes
and they clearly correspond to the spring pollen period
(see Additional file 1: Figure S1).
Weather data
Hourly weather data from LaGuardia Airport were ob-
tained from National Climatic Data Center (http://
www7.ncdc.noaa.gov/CDO/cdopoemain.cmd?datasetabbv=
DS3505&countryabbv=&georegionabbv=&resolution=40).
From the hourly observations, we computed daily mean
temperature and daily average relative humidity.
Air pollution data
Since previous studies in NYC found associations between
asthma outcomes and both ozone and fine particles
(PM2.5) during warm months [24, 25], we considered these
air pollutants as potential confounders. We obtained
gravimetrically-measured PM2.5 (24-h) and ozone (hourly)
data from the U.S. EPA’s Air Quality Subsystem. For
ozone, daily 8-h maximum values were first computed
from hourly data. We then computed daily citywide aver-
age values from available multiple monitors following
the approach used by Schwartz [26], which accounts
for differences in variance and mean between sites.
Data analysis
Figure 1 shows time-series plots of the outcomes, pollen
(ash is shown), weather and air pollutants. Both tree
pollen and air pollution concentrations are influenced by
weather conditions such as temperature increase and rain,
but unlike air pollution, each tree pollen type has a begin-
ning and an end in each spring (i.e., flowering period),
yielding an underlying broad bell-shaped concentration
trend, which can be observed in Fig. 1. Therefore, in
addition to time-series analysis, we also characterized the
timing and duration of the tree pollen periods.
Characterization of average peak calendar dates and
year-to-year variation in pollen and the outcomes
First, to characterize the general timing of the pollen pe-
riods and the outcomes, we standardized each series so
that its maximum height is 100 in each spring period.
Then, each series was temporally smoothed with an 11-
day moving average and then averaged across the study
years by calendar date. The resulting values were plotted
as density, yielding a “pollen calendar” with corresponding
figures for the outcomes.
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Fig. 1 Time-series plots of OTC allergy medication sales, asthma syndrome ED visits, pollen (ash is shown), weather, and air pollution, during
March 1 and June 10th, 2002-2012. The red horizontal dotted line for ash plot indicates 98th percentile level
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To assess if the year-to-year variation in seasonal peak
date for pollen corresponds to those for the outcomes
(i.e., does an early pollen season lead to an early peak in
the allergy outcomes?), we computed the average calendar
date of the five highest pollen levels in each season and
the corresponding values for the outcomes, and computed
Spearman’s rank correlation. However, asthma syndrome
ED visits time-series exhibits two groups of major peaks
within the March 1 – June 10th study time window, with
the first group occurring before mid-April and the second
group after mid-April (see Fig. 1). The spikes in the first
(earlier) group appear even before the levels of the early
spring pollen type (elm and poplar) rise, suggesting that
the first group of peaks in asthma syndrome ED visits is
unlikely due to pollen. Therefore, to focus on the second
group of peaks in asthma syndrome ED visits, which also
generally coincide with the largest peaks of OTC allergy
medication sales, for the outcomes, we considered the
dates after April 15th because the outcomes.
To assess if the duration of pollen season corresponds
to those for the outcomes (i.e., does a shorter pollen sea-
son lead to a narrower peak in the allergy outcomes?), we
defined the duration of the tree pollen season in each year
as the days between the dates at 10th and 90th temporal
cumulative percentiles of tree pollen concentrations and
the corresponding values for the outcomes, and computed
Spearman’s rank correlation. Again, for the outcomes, we
considered the dates after April 15th in computing the
duration.
Regression model to estimate the impacts of tree pollens
on the allergy and asthma morbidity
Pollen exposure metrics: The distributions of all the tree
pollen types were highly skewed. Our exploratory ana-
lysis of cross-correlation functions between pollen and
the outcomes also showed that log-transformed pollen
concentrations yielded better correlations than the raw
data. Therefore, we log-transformed pollen concentra-
tions (after adding 1) and used it as a pollen exposure
metric. Since log-transformation was not commonly
done in the past studies of pollen, we also evaluated sen-
sitivity of results to using three alternative pollen met-
rics: (1) re-scaled in each spring by dividing the daily
values by the maximum of that spring so that daily
pollen intensity takes values between 0 and 100; (2)
same as (1) but log-transformed; and, (3) raw data.
Regression model development: Based on preliminary
evaluations of cross-correlation functions between the
outcome and explanatory variables, we developed a re-
gression model to estimate multi-day effects rate ratios,
up to 3-day lags for OTC allergy medication sales and
up to 7-day lags for asthma syndrome ED visits at 98th
percentile distribution of pollen levels compared to 0th
percentile. We express rate ratios per zero-to-near-the-
peak (98th percentile) increase in pollen levels because
these two allergy indicators exhibit very sharp peaks
every spring, distinctly sharp in comparison to other sea-
sonal variations in the rest of the year (see Additional
file 1: Figure S1), clearly in response to the peak levels of
pollen. Of the eleven springs, the number of times the
98th percentile level was achieved or exceeded were 8 for
elm, 8 for poplar, 7 for maple, 7 for birch, 5 for beech, 6
for ash, 9 for sycamore/London planetree, 10 for oak,
and 6 for hickory, indicating that this is a near-peak level
that are observed in most of the springs for most of the
pollen types we analyzed. We estimated cumulative rate
ratios of the pollens’ impacts with a distributed lag
model using the R package ‘dlnm’ [27] with a quasi-
Poisson model accommodating over-dispersion, specify-
ing an unconstrained lag form and a linear functional
form. The model also adjusted for: (1) day-of-week; (2)
within-season temporal trends using natural cubic
splines of study days with 6° of freedom (d.f.) (deter-
mined by examining residual autocorrelation) per each
spring; (3) daily average relative humidity with the same
length of lags as the outcome, unconstrained for the lag
form and natural cubic splines with 2 d.f. for the func-
tional form; (4) daily average temperature fitted in the
same way as relative humidity; (5) PM2.5 with up to 2-
day lags with unconstrained lag form and a linear func-
tional form; and (6) ozone with up to 2-day lags fitted in
the same way as PM2.5. We applied the same model for
the four age groups of asthma syndrome ED visits.
We conducted additional analyses to examine sensitiv-
ity of results to alternative model specifications for both
outcomes: (1) using a third-degree polynomial distrib-
uted lag form rather than unconstrained lag form; (2)
using a more aggressive adjustment for within-season
temporal trends by using 8 d.f. per season; (3) without
adjustment for temperature and relative humidity; and
(4) without adjustment for PM2.5 and ozone.
All the analyses were conducted using R statistical
package version 3.03 (R Core Team, Vienna, Austria,
2014). The significance of statistical tests in the follow-
ing text is based on alpha = 0.05 and two-tailed test.
The Institutional Review Board of NYCDOH approved
the study protocol.
Results
Data distributions of daily values for all the variables are
shown in Table 1. All the tree pollen types are highly
skewed in part because the tree pollen concentrations
occur in a limited time window within the March 1st –
June 10th period. Correlation among the pollen types
ranged from weakly negative to moderately positive
(shown in the Additional file 1: Table S1).
Figure 2 shows the intensity of the level of tree pollens
averaged across eleven years. The average peak calendar
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dates of individual years are also superimposed. The esti-
mated average peak dates and durations are shown in
Table 2. The average peak date (May 2rd) for OTC al-
lergy medication sales occurs a few days after the aver-
age peak dates of mid-spring pollens, and the average
peak dates for asthma syndrome ED visits (May 11th)
follows that for OTC allergy medication sales. Maple
showed the longest average duration (25 days), while the
mid-spring tree pollens showed shorter durations. Thus,
the year-to-year variability in average peak calendar dates,
especially for the mid-spring pollens, is small (i.e., standard
deviation < 10 days).
Among Spearman rank correlations of the correspond-
ence between the peak dates of pollens and those for
OTC allergy medication sales, birch, beech, ash, syca-
more/London planetree, and oak were statistically sig-
nificant; and beech and oak were significant for asthma
syndrome ED visits (Table 2). Diagrams of temporal cor-
respondence between peaks of tree pollens and OTC al-
lergy medication sales in each of the ten years are shown
in the (Additional file 1: Figure S2). Spearman rank cor-
relations between the estimated durations also showed
significant relationships for birch, beech, and oak for
both outcomes, and the durations of the two outcomes
were also significantly correlated.
Figure 3 shows the estimated cumulative rate ratio
for both outcomes per 0-to-98th percentile increase for
each of the nine pollen types. Neither elm nor poplar
was significantly associated with these two outcomes.
The magnitude of associations is substantial, especially
mid-spring tree pollen types (maple, birch, beech, ash,
oak, and sycamore/London planetree) with cumulative
rate ratios up to 2.0 for OTC allergy medication sales
(e.g., 1.9 [95 % CI: 1.7, 2.1] for ash pollen) and up to
1.7 for asthma syndrome ED visits (e.g., 1.7 [95 % CI:
1.5, 1.9] for ash pollen). The lagged associations for
asthma syndrome ED visits were longer than those for
OTC allergy medication sales (shown in the Additional
file 1: Figure S3).
The analysis of asthma syndrome ED visits by age
group found strong age-dependency (Fig. 4). For most
of the tree pollens, the 5-17 age group showed the
strongest associations (e.g., a cumulative rate ratio of
2.6 [95 % CI: 2.1, 3.1] per 0-to-98th percentile increase
for ash pollen), while the associations were generally
null for both the 0-4 and 65+ age groups.
Table 1 Data distribution during March 1st through June 10th, 2002-2012 (2002-2011 for OTC allergy medication sales)
Variables Mean S.D. Min. 25 % 50 % 75 % 98 % Max.
OTC Allergy Medication Sales (# units sold/day) 3493 1953 901 2263 2943 4086 9565 17971
Asthma Syndrome ED Visits (visits/day)
All Ages 269.0 71.6 104 222 254 298 468 704
Age 0-4 47.5 11.7 15 39 47 55 73 100
Age 5-17 64.2 30.8 18 43 58 77 155 243
Age 18-39 65.1 23.0 27 51 60 73 133 215
Age 40-64 72.0 18.1 32 60 70 81 122 169
Age 65+ 20.1 5.7 7 16 20 24 32 47
Spring Tree Pollen (grains/m3)
Elm 8.7 39.9 0 0 0 2.2 97.2 624.7
Poplar 6.7 25.8 0 0 0 1.8 77.3 380.1
Maple 15.3 101 0 0 0 7.2 130.0 3091.2
Birch 142.8 649.1 0 0 1.8 21.6 1680.3 10235.3
Beech 2.6 11.6 0 0 0 0 30.9 162.0
Ash 17.9 73.1 0 0 0 2.2 223.3 1029.7
Syc./London plane 9.4 43.6 0 0 0 0 97.2 696.0
Oak 190.6 683.9 0 0 2.1 57.0 1932.1 13040.4
Hickory 11.3 41.4 0 0 0 2.2 131.4 768.9
Weather
Temperature (°C) 12.5 6.7 -7.7 8.1 12.6 17 26.3 31.8
Rel. Humid. (%) 59.7 17.4 20.8 44.6 58.8 73.8 93.3 99.3
Air Pollutant
PM2.5 (μg/m3) 10.9 6.4 1.2 6.3 9.1 13.8 28.6 42.6
Ozone (ppb) 35.7 11.8 3.9 28.4 34.8 41.8 66.7 93.5
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Of the two air pollutants, ozone was consistently and sta-
tistically significantly associated with both OTC allergy
medication sales and asthma syndrome ED visits (results
not shown). For example, the largest estimated cumulative
rate ratio for ozone at lag 0 through 2 days for OTC allergy
medication sales was 1.12 (95 % CI: 1.08, 1.16) with oak in
the model, per 10 ppb increase. In contrast, PM2.5 showed
small but negative associations with OTC allergy medica-
tion sales (which were sensitive to weather adjustment, as
the associations were positive without the weather terms)
and consistently null associations with asthma syndrome
ED visits during the spring season (results not shown).
The alternative pollen metrics generally showed com-
parable rate ratios for both outcomes except for the
raw data, which showed the poorest associations with
both outcomes (result shown in the Additional file 1:
Figure S4).
The estimated tree pollen rate ratios for both OTC
allergy medication sales and asthma syndrome ED visits
were generally insensitive to alternative model specifica-
tions in terms of a lag form of pollen, a more aggressive
temporal adjustment, and adjustment for weather and
air pollution (shown in the Additional file 1: Figure S5).
Discussion
Our study analyzed more individual clinically-relevant
spring tree pollen types than any of the past observa-
tional time-series studies of allergy/asthma outcomes.
Our study is also unique in that two allergy/asthma
outcomes were analyzed using a consistent approach.
We found that mid-spring pollen types (maple, birch,
beech, ash, sycamore/London plane tree, and oak)
showed the strongest associations with both OTC al-
lergy medication sales and asthma syndrome ED visits
Fig. 2 Average intensity of OTC allergy medication sales, asthma syndrome ED visits, spring tree pollens smoothed with an eleven-day moving
average (and log-transformed for tree pollens) averaged by calendar date across eleven years (2002-2012; 2002-2011 for the medical sales data).
Average calendar dates of individual years’ five highest levels are also shown
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consistently. Associations were even strongest in chil-
dren (ages 5-17). These findings add to the existing evi-
dence from the population-based studies of the impacts
of tree pollens on allergy/asthma outcomes, but some
aspects of our analyses are more elaborate and merit
further discussion.
Timing, duration, and magnitude of association
Our rank correlation analysis of the year-to-year corres-
pondence between the peak calendar dates for pollen
and the outcomes indicates that the timing of the peak
abundance period for some of the mid-spring pollen
types were significantly associated with the correspond-
ing timing for OTC allergy medication sales (birch,
beech, ash, and sycamore) and asthma ED visits (beech
and oak), implying that when the pollen peak appeared
early in the spring, so did the peaks of the outcomes.
Likewise, the rank correlation results of the year-to-year
correspondence in the 10th-to-90th temporal cumulative
durations indicate that the durations of birch, beech,
and oak were significantly associated with those for both
outcomes, implying a shorter flowering period of these
pollen types would lead to a shorter associated period of
elevated counts of these outcomes. While the relatively
small sample size of these rank correlations of year-to-year
variation (n = 10 for the medication sales data, n = 11
for the asthma syndrome ED visits data) limits the in-
terpretation of these results, they provide an alternative
and complementary approach to the usual time-series
analysis of daily data, which we also conducted.
The estimated magnitude of the mid-spring tree pollens’
impacts on OTC allergy medication sales (cumulative rate
ratio up to 2.0 per 0-to-98th percentile increase) and
asthma syndrome ED visits (up to 1.7 for all-age; up to 2.6
for age 5-17 group) is quite “large” for a temporary varying
environmental risk factor and certainly larger than those
for air pollution, though, unlike air pollution, the dura-
tions of these tree pollens are limited (e.g., 2 to 4 weeks)
per year. We reviewed other recent studies that examined
tree pollen impacts on allergy and asthma outcomes, and
found that, while direct comparisons are difficult because
rate ratios are computed for different increments (e.g.,
inter-quartile-range), these studies also reported substan-
tive impacts (e.g., rate ratios > 1.2 had they been computed
per 0-to-98th percentile increase) [5, 9, 11]. Our rate ratios
may also be larger compared to those reported in the past
studies in part because they are cumulative rate ratios over
multiple days with longer lags (i.e., 0-7 days for asthma
syndrome ED visits) than previously considered in other
studies.
Coherence of associations with tree pollens between the
two outcomes
We see coherence in the associations between tree pol-
lens and OTC allergy medication sales and asthma syn-
drome ED visits in that they were both most strongly
associated with mid-spring tree pollens and not associ-
ated with the early-spring pollens (elm and poplar). The
average peak date for OTC allergy medication sales oc-
curs about 9 days before the average peaks date for
asthma syndrome ED visits, and the associations with
tree pollens for asthma syndrome ED visits exhibit lon-
ger lags than for OTC allergy medication sales. The rank
correlation analysis indicated that the elevated durations




calendar datesa, b (S.D.)
Average 10th-to-90th %
Durationb, c days (S.D.)
Rank Correlationd of Peak dates Rank Correlationd of Duration
OTC Allergy Med. Asthma syndrome
ED visits
OTC Allergy Med. Asthma syndrome
ED visits
Elm 31-Mar (10.6) 15.0 (10.1) 0.55 0.50 -0.37 -0.38
Poplar 14-Apr (9.9) 17.0 (6.9) 0.35 0.60 -0.15 -0.20
Maple 18-Apr (13.5) 25.1 (10.2) 0.62 0.37 -0.28 -0.29
Birch 27-Apr (5.7) 17.1 (9.6) 0.67 0.40 0.76 0.88
Beech 30-Apr (5.7) 18.9 (6.1) 0.80 0.74 0.73 0.84
Ash 28-Apr (7.3) 12.6 (4.0) 0.90 0.49 0.19 0.33
Sycamore/London
planetree
28-Apr (8.8) 12.5 (4.1) 0.91 0.51 0.32 0.49
Oak 4-May (9.3) 12.5 (5.5) 0.92 0.66 0.86 0.85
Hickory 27-May (6.7) 17.8 (5.7) 0.09 0.05 0.49 0.42
OTC Med Sales 2-May (7.9) 44.7 (2.2) NA 0.47 NA 0.89
Asthma Syndrome
ED visits
11-May (9.9) 46.5 (1.4) 0.47 NA 0.89 NA
Note: aFor each spring, the average peak date is defined as the average calendar date of the five highest pollen concentrations; bFor the outcomes, this
computation was done for on and after April 15th; cFor each spring, the 10th-to-90th percentile duration is the period between the dates with the 10th and 90th
cumulative sum percentile of concentrations; dSpearman’s rank correlation between the average peak date or duration of tree pollen vs. that of the outcome
across years. The bold-faced correlations are significant at alpha = 0.05 level
Ito et al. Environmental Health  (2015) 14:71 Page 8 of 12
of these outcomes were significantly correlated, but not
their average peak dates. These results may suggest that
elevated levels of tree pollens induce and/or exacerbate
allergic rhinitis in both asthmatic and non-asthmatic
populations, but these two outcomes need not have hap-
pened in the same individuals. We currently do not have
information on consumer reasons for the temporal in-
crease in purchase of these medications (i.e., as a pre-
ventive measure or in response to symptoms onset). The
OTC allergy medication sales averaged about 3,500
(representing only ~20 % coverage of retail drug stores
in the city) sales per day, whereas asthma syndrome ED
visits average about 260 visits per day (with ~95 % ED
visits coverage in the city) during the spring period.
Exposure misclassification
One major limitation of our study was potential expos-
ure misclassification from using data from a monitor
outside of New York City. A recent review [28] also sug-
gests that within-city variation of tree pollen levels can
be substantive. However, in our previous analysis of peak
dates of three tree pollens (birch, maple, and oak) and
OTC allergy medication sales in years 2003-2008, the es-
timated impacts were similar when the sales from each
of five boroughs were separately analyzed, suggesting
that the tree pollen data from outside the city can serve
as a useful indicator of exposures to these tree pollens
[4]. We speculate that the timing of pollen release is not
significantly different between the trees in the city and
those outside the city within the metro area, as shown in
other locales [29]. Nevertheless, the nature and the ex-
tent of possible exposure errors for the tree pollens in
our setting have not been characterized. The extent of
such exposure misclassification error may also be dif-
ferent across these tree pollens. Therefore, some of us
are currently investigating this issue by measuring
pollen counts daily in the central NYC location and
also collecting data using integrated pollen trap sam-
plers at 45 locations within NYC (Weinberger et al.,
unpublished data) using the infrastructure of New York
City Community Air Survey [30]. Our current analysis
also expressed the rate ratio per near-peak (i.e., 98th
percentile) pollen levels rather than per grains/m3 to
minimize a potential “scaling error” that can result
Fig. 3 Cumulative rate ratios per 0-to-98th percentile increase in spring tree pollen levels for: (a) OTC allergy medication sales (0-3 days); and
(b) asthma syndrome ED visits (0-7 days)
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from the influence of local trees on the pollen levels
measured at a single location.
Air pollution effects
The lack of PM2.5 association in this analysis may be due
to the relatively low concentrations in the spring study
period. In contrast, ozone was consistently associated with
both outcomes, though the magnitude of its effect size
was smaller than that for tree pollens. Past controlled
studies involving asthmatic subjects suggest synergistic
effects of ozone and allergens [31–34]. Ozone may also
modify allergenicity of pollens [35, 36]. However, we were
unable to specifically test an interaction effect of ozone
and tree pollen because there were not sufficient days of
high and low ozone with and without tree pollen peaks.
Relative importance of tree pollen types
We found that the mid-spring tree pollens were most
consistently and strongly associated with both OTC al-
lergy medication sales and asthma syndrome ED visits.
These two allergy outcomes were also consistently not
associated with elm and poplar. These results are in part
consistent with the results from the study of allergy pa-
tients in New York City using skin prick test [3], which
Fig. 4 Cumulative rate ratios per 0-to-98th percentile increase in spring tree pollen levels for asthma syndrome ED visits (0-7 days) by age groups
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concluded that the hypersensitivity to tree pollens most
often was manifested with allergy to oak, birch, and
maple, and that identifying beech, poplar, and elm
hypersensitivity added little towards identifying patients
who are allergic to tree pollen.
There is a limitation to linking the relative strength of
observed associations across the tree pollens to their
corresponding sensitization potencies. Because these tree
pollens’ peaks appear in a generally expected order (e.g.,
elm the earliest and hickory the last), those whose peaks
appear later in the spring (e.g., hickory) may not appear
to have associations only because the largest impacts
might have already taken place (i.e., the allergy medica-
tions purchased; subjects have visited ED so that the
conditions have been controlled) from the pollens that
appear earlier in the spring. Also, the mid-spring tree
pollens may appear to have the largest impacts on these
outcomes possibly because their concentrations are sim-
ultaneously high during the relatively narrow time win-
dow. Thus, the apparent relative impacts of tree pollens
on allergy/asthma outcomes may depend on the domin-
ant or mix of pollen taxa in a given city or region.
Age dependence of association
We found that the tree pollens’ associations with
asthma syndrome ED visits were strongest in children
(age 5-17). The weaker associations for the very young
(age 0-4) and the elderly (age 65+) may be due to
greater uncertainty in identifying (as reported by self or
family members) asthma in these age groups. Of the
asthma ED visits studies that also examined multiple
age groups, Darrow et al. [9] also found that age 5-17
group showed the strongest associations with oak com-
pared to age groups 0-4 or 18 +.
Climate change implications
Public health impacts of pollen could be affected in a
number of different ways as climate changes in coming
years. It has been hypothesized that climate change may
contribute to the rise in asthma [37]. Specific global
warming adaptation measures such as urban tree plant-
ing to combat urban heat island could also impact popu-
lation level exposure to allergenic pollen. General
guidelines for the choice of urban trees have been pro-
posed such as the use of low pollen producing species
[38], but specific choice of tree(s) for a given city may
need to consider relative importance of pollen types that
have impacts on asthma/allergy outcomes observed,
such as we have presented here. Our result suggests that
changes in timing of pollen season onset will influence
timing of increase in allergy/asthma outcomes. However,
assessment of the impact of climate change on tree
season length and pollen abundance was outside the
scope of this analysis.
Conclusions
Tree pollens peaking in mid-spring exhibit substantive
impacts on allergy and asthma morbidity. The pollen’s
association with asthma syndrome ED visits was most
pronounced in children. Given the relatively narrow
time window of these pollens’ peak occurrences, public
health and clinical approaches to anticipate and reduce
allergy and asthma morbidity from spring pollen should
be developed. Because the dominant taxa and mixture of
tree pollens vary from region to region, similar assess-
ment of the impacts of individual tree pollens on allergy
and asthma outcomes would be beneficial in developing
city/region specific public health programs to mitigate
the adverse impacts of tree pollens and to plan for the
future impact of climate change on tree pollens.
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